Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 379.50
Ask: 380.00
Change: 4.50 (1.20%)
Spread: 0.50 (0.132%)
Open: 376.00
High: 381.50
Low: 375.00
Prev. Close: 375.50
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Dec 2019 07:04

RNS Number : 6034W
Tyman PLC
12 December 2019
 

TYMAN PLC

("Tyman" or the "Company" or the "Group")

 

Directorate Change

 

Announcement of non-executive director succession

Tyman, a leading international supplier of engineered components and access solutions to the construction industry, is pleased to announce the appointment of Dr Paul Withers as a Non-Executive Director with effect from 1 February 2020.

Paul will succeed Mark Rollins, who will be stepping down from the Board on 31 March 2020, and will take over the roles of Chairman of the Remuneration Committee and Senior Independent Director ("SID") from that date. Paul will join the Audit, Nomination and Remuneration Committees with effect from the date of his appointment to the Board on1 February 2020.

Paul brings extensive international experience and in particular strong knowledge of US markets to the Board, both as an executive and non-executive director. He is SID and Chair of the Remuneration Committee for both Keller Group plc and Devro plc. Paul's executive career was spent at BPB plc, the international building materials business where he was Group Managing Director. He has also been a Non-Executive Director, SID and Chair of the Remuneration Committee of both Premier Farnell plc and Hyder Consulting plc.

Martin Towers, Chair of Tyman, commented:

"I am delighted to welcome Paul as the next Chair of the Remuneration Committee and SID. Paul's breadth of experience in international manufacturing businesses, coupled with strategic insight gained from his extensive career, make him an excellent addition to our Board."

"I also would like to thank Mark for his wise counsel and significant contribution to the Company during his five years on the Board. Mark will depart with the Board's very best wishes for the future."

12 December 2019

There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.

Enquiries:

Tyman plcMartin Towers, Chairman 020 7976 8000 www.tymanplc.com

MHP Communications 020 3128 8100Reg Hoare

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMMMZMZNGLZG
Date   Source Headline
24th Apr 202410:42 amGNWMan Group PLC : Form 8.3 - Tyman plc
24th Apr 20249:02 amPRNForm 8.3 - Tyman PLC
23rd Apr 20244:48 pmRNSAlantra EQMC AM TYMN Form 8.3 - Tyman plc
23rd Apr 20244:31 pmRNSForm 8.3 - Tyman plc (Replacement)
23rd Apr 20243:26 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20243:25 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20243:20 pmRNSForm 8.3 - Tyman plc
23rd Apr 20243:06 pmRNSForm 8.3 - Tyman plc
23rd Apr 20242:58 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20242:54 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20242:43 pmRNSForm 8.3 - Tyman plc
23rd Apr 20242:42 pmRNSForm 8.3 - Offer for Tyman plc
23rd Apr 20242:37 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20242:20 pmRNSForm 8.3 - QUANEX BUILDING PRODUCTS CORP
23rd Apr 20242:17 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20242:17 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20241:59 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20241:58 pmRNSForm 8.3 - Tyman plc
23rd Apr 20241:55 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tyman plc
23rd Apr 20241:22 pmRNSForm 8.3 - Tyman plc
23rd Apr 20241:14 pmEQSForm 8.3 - Apex Fundrock Limited : Re Tyman plc
23rd Apr 202412:48 pmGNWForm 8.3 - Tyman plc
23rd Apr 202412:22 pmRNSForm 8.3 - Tyman plc
23rd Apr 202412:10 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
23rd Apr 202412:09 pmGNWMan Group PLC : Form 8.3 - Tyman plc
23rd Apr 202411:57 amRNSForm 8.3 - Tyman Plc
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.